scholarly journals Using the health action process approach to predict and improve health outcomes in individuals with type 2 diabetes mellitus

2014 ◽  
pp. 469 ◽  
Author(s):  
Barbara Mullan ◽  
Mariana MacPhail ◽  
Louise Sharpe ◽  
Caroline MacCann ◽  
Jemma Todd
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Health Outcomes ◽  
Process Approach ◽  
Health Action Process Approach ◽  
Health Action ◽  
Action Process ◽  
Improve Health

scholarly journals Using health action process approach to determine diet adherence among patients with Type 2 diabetes

2020 ◽  
Vol 9 (1) ◽  
pp. 170
Author(s):  
Elham Shakibazadeh ◽  
Soheila Ranjbaran ◽  
Davoud Shojaeizadeh ◽  
Tahereh Dehdari ◽  
Mehdi Yaseri
Keyword(s):  
Type 2 Diabetes ◽  
Process Approach ◽  
Health Action Process Approach ◽  
Diet Adherence ◽  
Health Action ◽  
Action Process

scholarly journals Determinants of medication adherence among Iranian patients with type 2 diabetes: An application of health action process approach

Heliyon ◽  
2020 ◽  
Vol 6 (7) ◽  
pp. e04442
Author(s):  
Soheila Ranjbaran ◽  
Davoud Shojaeizadeh ◽  
Tahereh Dehdari ◽  
Mehdi Yaseri ◽  
Elham Shakibazadeh
Keyword(s):  
Type 2 Diabetes ◽  
Medication Adherence ◽  
Process Approach ◽  
Health Action Process Approach ◽  
Health Action ◽  
Action Process ◽  
Iranian Patients

scholarly journals The effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial

2022 ◽  
Vol 14 (1) ◽  
Author(s):  
Soheila Ranjbaran ◽  
Davoud Shojaeizadeh ◽  
Tahereh Dehdari ◽  
Mehdi Yaseri ◽  
Elham Shakibazadeh
Keyword(s):  
Type 2 Diabetes ◽  
Medication Adherence ◽  
Self Efficacy ◽  
Controlled Trial ◽  
Process Approach ◽  
Health Action Process Approach ◽  
Health Action ◽  
Action Process ◽  
Hba1c Levels

Abstract Background Diabetes is a major cause of worldwide morbidity and mortality. Diet and medication non-adherence are common among individuals with diabetes, making glycemic control difficult to attain. This study aimed to evaluate an intervention designed based on Health Action Process Approach (HAPA) to improve adherence to diet and medication among patients with type 2 diabetes in Tehran, Iran. Methods The study was a randomized controlled trial. A total of 248 patients with type 2 diabetes who had low diet and medication adherence were randomly allocated into two intervention (n  = 124) and control (n  = 124) groups. Intervention group received educational intervention during three months. HAPA constructs, diet and medication adherence, and Hemoglobin A1c (HbA1c) levels were assessed at baseline, one month and six months after the intervention. Mixed Model Analysis was used to compare between and within group changes in the outcomes. Results There was a statistically significant improvement in HbA1c levels after six months (7.77 ± 1.36% vs. 8.07 ± 1.52%, 95% CI, p  < 0.001). Diet and medication adherence, intention, task self-efficacy, coping self-efficacy, recovery self-efficacy, action and coping planning, barriers, benefits and perceived social support were significantly improved one month and six months after the intervention (p  < 0.001). Conclusion Our intervention designed based on health action process approach led to improvements in diet and medication adherence, and HbA1c among the patients within one and six months. Trial registration: IRCT, IRCT20151208025431N4. Registered 10 March 2018, https://fa.irct.ir

Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM)

2016 ◽  
Vol 35 (3) ◽  
pp. 375-396 ◽  
Author(s):  
Michael Willis ◽  
Pierre Johansen ◽  
Andreas Nilsson ◽  
Christian Asseburg
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Health Outcomes

scholarly journals Association between mental health comorbidity and health outcomes in type 2 diabetes mellitus patients

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Inmaculada Guerrero Fernández de Alba ◽  
Antonio Gimeno-Miguel ◽  
Beatriz Poblador-Plou ◽  
Luis Andrés Gimeno-Feliu ◽  
Ignatios Ioakeim-Skoufa ◽  
...  
Keyword(s):  
Mental Health ◽  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Substance Use ◽  
Type 2 Diabetes Mellitus ◽  
Health Outcomes ◽  
Substance Use Disorder ◽  
Emergency Room Visit ◽  
Mental Health Problems

Abstract Type 2 diabetes mellitus (T2D) is often accompanied by chronic diseases, including mental health problems. We aimed at studying mental health comorbidity prevalence in T2D patients and its association with T2D outcomes through a retrospective, observational study of individuals of the EpiChron Cohort (Aragón, Spain) with prevalent T2D in 2011 (n = 63,365). Participants were categorized as having or not mental health comorbidity (i.e., depression, anxiety, schizophrenia, and/or substance use disorder). We performed logistic regression models, controlled for age, sex and comorbidities, to analyse the likelihood of 4-year mortality, 1-year all-cause hospitalization, T2D-hospitalization, and emergency room visit. Mental health comorbidity was observed in 19% of patients. Depression was the most frequent condition, especially in women (20.7% vs. 7.57%). Mortality risk was higher in patients with mental health comorbidity (odds ratio 1.24; 95% confidence interval 1.16–1.31), especially in those with substance use disorder (2.18; 1.84–2.57) and schizophrenia (1.82; 1.50–2.21). Mental health comorbidity also increased the likelihood of all-cause hospitalization (1.16; 1.10–1.23), T2D-hospitalization (1.51; 1.18–1.93) and emergency room visit (1.26; 1.21–1.32). These results suggest that T2D healthcare management should include specific strategies for the early detection and treatment of mental health problems to reduce its impact on health outcomes.

Sign in / Sign up

Export Citation Format

Share Document